• Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Denmark France Germany Hungary +5
  • Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DNL952 in Adults with Late‑Onset Pompe Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    Germany The Netherlands
  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    France Germany Hungary Poland Romania Slovakia +1
  • Safety and effectiveness of ponatinib and asciminib in chronic myeloid leukemia patients resistant to these drugs

    Recruiting

    2 1 1 1
    Spain
  • Study of FLUDEOXYGLUCOSE (18F) PET Imaging of Brain Metabolism in Patients with Persistent Post‑COVID Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Phase 2 Randomized Study of Povetacicept to Assess Safety and Effectiveness in Adults with Generalized Myasthenia Gravis

    Recruiting

    2 1
    Investigated Drugs:
    Poland
  • Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Poland
  • Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Poland
  • Lidocaine Hydrochloride, Sodium Chloride, and Betamethasone Injections for Adults with Adhesive Capsulitis: A Pilot Efficacy Study

    Recruiting

    2 1 1
    Investigated Diseases:
    France
  • Safety and Antitumor Activity of PF-08634404 Alone or with Enfortumab Vedotin in Adults with Locally Advanced or Metastatic Urothelial Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    The Netherlands Spain

powered by